关于 "Insulin Receptor" 的结果21+ 个结果
筛选:Tyrosine Kinase×
- MID-1CAS: 312608-54-1
MID-1 is a disruptor of MG53-IRS-1 (Mitsugumin 53-insulin receptor substrate-1) interaction, which can disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.
- Insulin degludecCAS: 844439-96-9
Insulin degludec 是一种超长效形式的胰岛素,用于治疗 1 型和 2 型糖尿病引起的高血糖。Insulin degludec 结合胰岛素受体的 IC50 值为 19.59 nM/L。Insulin degludec 可用于 1 型和 2 型糖尿病的研究。
- cFMS Receptor Inhibitor IVCAS: 959626-45-0
cFMS Receptor Inhibitor IV (Compound 42) 是一种有效的 cFMS 抑制剂,IC50 为 0.017 μM。
- MSDC-0602KCAS: 1314533-27-1
MSDC-0602K is a insulin sensitizer that modulates the mitochondrial pyruvate carrier (MPC).
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC13988 | HNMPA | 132541-52-7 | Insulin Receptor | ||
An insulin receptor tyrosine kinase inhibitor | |||||
| GC39189 | S961 TFA | - | Peptides | ||
S961 is a biosynthetic insulin receptor antagonist that inhibits cellular proliferation and colony formation in breast tumour cells. | |||||
| GC25881 | S961 | 1083433-49-1 | IGF1R | ||
S961 is a biosynthetic insulin receptor antagonist that inhibits cellular proliferation and colony formation in breast tumour cells. | |||||
| GC61516 | MID-1 | 312608-54-1 | Insulin Receptor | ||
MID-1 is a disruptor of MG53-IRS-1 (Mitsugumin 53-insulin receptor substrate-1) interaction, which can disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake. | |||||
| GC31303 | Insulin(cattle) (Insulin from bovine pancreas) | 11070-73-8 | Peptides | ||
胰岛素是一种由21个和30个氨基酸组成的激素蛋白质。 | |||||
| GC67998 | Insulin degludec | 844439-96-9 | Insulin Receptor | ||
Insulin degludec 是一种超长效形式的胰岛素,用于治疗 1 型和 2 型糖尿病引起的高血糖。Insulin degludec 结合胰岛素受体的 IC50 值为 19.59 nM/L。Insulin degludec 可用于 1 型和 2 型糖尿病的研究。 | |||||
| GC69283 | Insulin glargine | 160337-95-1 | Insulin Receptor | ||
Insulin glargine 是一种长效胰岛素类似物。Insulin glargine 可用于研究糖尿病。 | |||||
| GC70310 | Insulin glulisine | 207748-29-6 | Insulin Receptor | ||
Insulin glulisine(HMR 1964)是一种速效胰岛素类似物,它模拟了生理性人胰岛素的药代动力学和药效学特征。 | |||||
| GC31526 | Insulin levels modulator | 1019254-94-4 | Insulin Receptor | ||
Insulinlevelsmodulator可用于治疗糖尿病。 | |||||
| GC74561 | Insulin efsitora alfa | 2131038-11-2 | Insulin Receptor | ||
Insulin efsitora alfa (LY-3209590)是胰岛素受体(IR)的选择性激动剂。 | |||||
| GC65976 | cFMS Receptor Inhibitor IV | 959626-45-0 | c-FMS | ||
cFMS Receptor Inhibitor IV (Compound 42) 是一种有效的 cFMS 抑制剂,IC50 为 0.017 μM。 | |||||
| GC34528 | cFMS Receptor Inhibitor II | 959860-85-6 | c-FMS | ||
cFMSReceptorInhibitorII是一种CSF1R激酶抑制剂。CSF-1是一种细胞因子。 | |||||
| GC11312 | EGFR Inhibitor | 879127-07-8 | EGFR | ||
A selective antagonist of the EGFR | |||||
| GC11134 | ALW-II-41-27 | 1186206-79-0 | Ephrin Receptor | ||
ALW-II-41-27 是一种 Eph 家族酪氨酸激酶抑制剂,抑制 Eph2 的 IC50 为 11 nM。 | |||||
| GC44583 | PD 089828 | 179343-17-0 | PDGFR | ||
An inhibitor of EGFR, PDGFβ, FGF, and c-Src | |||||
| GC19508 | BLU-782 | 2141955-96-4 | ALK | ||
BLU-782 是一种口服精准疗法,专门设计用于选择性靶向突变体 ALK2。 | |||||
| GC14905 | Demethylasterriquinone B1 | 78860-34-1 | Insulin Receptor | ||
A natural insulin mimic | |||||
| GC64431 | MSDC-0602K | 1314533-27-1 | Insulin Receptor | ||
MSDC-0602K is a insulin sensitizer that modulates the mitochondrial pyruvate carrier (MPC). | |||||
| GC14464 | Vatalanib | 212141-54-3 | VEGFR | ||
A potent and selective VEGF receptor inhibitor | |||||
| GC16421 | Cediranib (AZD217) | 288383-20-0 | PDGFR | ||
An inhibitor of VEGF receptor tyrosine kinases | |||||
| GC34708 | Pexidartinib hydrochloride | 2040295-03-0 | c-Kit | ||
A multi-targeted receptor tyrosine kinase inhibitor | |||||
